Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Cencora (ABG) Stock Price & Analysis

0 Followers

ABG Stock Chart & Stats

CHF 273.59CHF 0.00(0.00%)
At close: 5:30 PM GMT+1
CHF250CHF260CHF270Jul 22Oct 28
Day’s Range
CHF 273.59 - CHF 292.61
52-Week Range
CHF 242.59 - CHF 292.61
Previous Close
CHF 273.59
Volume
N/A
Average Volume (3M)
1
Market Cap
CHF 55.77B
Enterprise Value
CHF 63.96B
Total Cash (Recent Filing)
CHF 4.88B
Total Debt (Recent Filing)
CHF 11.27B
Price to Earnings (P/E)
19.4
Beta
0.09
Next Earnings
Feb 03, 2027 (Est.)
EPS Estimate
3.8
Next Dividend Ex-Date
N/A
Dividend Yield
0.70%

Bulls Say, Bears Say

Bulls Say

Record Operating Performance

Record operating income and earnings growth indicate that Cencora is converting its large distribution platform into improving profitability. The combination of scale, stronger execution, and better earnings conversion supports continued investment and reinforces the company’s ability to compound results over multiple quarters.

Specialty Platform Expansion

Cencora is positioned in a faster-growing specialty market through distribution, provider services, oncology, retina, and clinical-trial capabilities. This broader platform can deepen customer relationships, support higher-value services, and provide a durable growth engine beyond traditional pharmaceutical distribution.

Strong Cash Generation

Substantial free cash flow gives Cencora flexibility to fund infrastructure, specialty expansion, acquisitions, debt service, and shareholder returns. The ability to generate cash at this scale strengthens strategic execution and provides an internal funding source for the company’s long-term growth priorities.

Bears Say

Elevated Leverage

Cencora’s debt-heavy capital structure increases sensitivity to interest costs, refinancing conditions, and working-capital swings. Although equity has improved from negative levels, elevated leverage can constrain financial flexibility and make acquisitions or shareholder returns more dependent on sustained cash generation.

Structurally Thin Margins

Very thin margins are inherent to Cencora’s distribution model but leave limited protection if operating costs, pricing pressure, or product mix weaken. Small changes in gross profit can therefore have an outsized effect on earnings, making sustained efficiency and specialty mix improvement important to long-term profitability.

Moderating Growth Outlook

The expected slowdown from fiscal 2026’s stronger performance suggests that near-term growth is becoming less broad-based. Moderation in consolidated revenue and operating income can reduce operating leverage, while portfolio changes and business headwinds make it harder for the distribution franchise to maintain its recent pace.

Cencora News

ABG FAQ

What was Cencora’s price range in the past 12 months?
Cencora lowest stock price was CHF242.59 and its highest was CHF292.61 in the past 12 months.
What is Cencora’s market cap?
Cencora’s market cap is CHF55.77B.
When is Cencora’s upcoming earnings report date?
Cencora’s next earnings report is estimated for Feb 03, 2027 (not yet confirmed), which is in 82 days.
How were Cencora’s earnings last quarter?
Cencora released its earnings results on Nov 04, 2026. The company reported CHF3.878 earnings per share for the quarter, beating the consensus estimate of CHF3.813 by CHF0.066.
Is Cencora overvalued?
According to Wall Street analysts Cencora’s price is currently Undervalued.
Does Cencora pay dividends?
Cencora does not currently pay dividends.
What is Cencora’s EPS estimate?
Cencora’s EPS estimate is 3.80.
How many shares outstanding does Cencora have?
Cencora has 190,827,160 shares outstanding.
What happened to Cencora’s price movement after its last earnings report?
Cencora reported an EPS of CHF3.878 in its last earnings report, beating expectations of CHF3.813. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cencora?
Hedge funds hold Cencora shares: the largest hedge-fund position in Cencora is 170,935,345 shares, and hedge funds increased their holdings by 21.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology